Axsome Therapeutics, Inc.
NasdaqGM:AXSM
$ 75.64
+ $3.14 (4.33%)
$ 75.64
+ $3.14 (4.33%)
End-of-day quote: 05/13/2024

AXSM - Axsome Therapeutics Stock Prediction 2025 - 2030

8 years of reliable Axsome Therapeutics stock forecast. The Wall Street analysts predict Buy for AXSM. See at a glance whether NasdaqGM:AXSM will rise in the future.

$0.00
Forecast 2023
$90.05
Forecast 2025
$153.05
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$90.05
Forecast 2030
$153.05
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.12
Price-to-book Ratio
24.96
Market Cap
3.50B
TEV
3.46 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$114.08

Axsome Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Axsome Therapeutics Stock Forecast 2023

$115.00

In the last five quarters, Axsome Therapeutics’s Price Target has risen from $92.88 to $114.08 - a 22.83% increase. Eight analysts predict that Axsome Therapeutics’s share price will increase in the coming year, reaching $115.00. This would represent an increase of 0.81%.

52.04%
52.04
Last update: 05/13/2024

Highest Price Target $190.00

Average Price Target $115.00

Lowest Price Target $97.00

Axsome Therapeutics Stock Forecast 2025

Stock Prediction for the Price of One Axsome Therapeutics Share in Jan 2025.

In Jan 2025 analysts predict a share price of $81.75. An increase of 8.07% compared to today's share price.

Stock Prediction for the Price of One Axsome Therapeutics Share in Feb 2025.

In Feb 2025 analysts predict a share price of $82.50. An increase of 9.07% compared to today's share price.

Stock Prediction for the Price of One Axsome Therapeutics Share in Mar 2025.

In Mar 2025 analysts predict a share price of $83.26. An increase of 10.07% compared to today's share price.

Stock Prediction for the Price of One Axsome Therapeutics Share in Apr 2025.

In Apr 2025 analysts predict a share price of $84.01. An increase of 11.07% compared to today's share price.

Stock Prediction for the Price of One Axsome Therapeutics Share in May 2025.

In May 2025 analysts predict a share price of $84.77. An increase of 12.07% compared to today's share price.

Stock Prediction for the Price of One Axsome Therapeutics Share in Jun 2025.

In Jun 2025 analysts predict a share price of $85.52. An increase of 13.07% compared to today's share price.

Stock Prediction for the Price of One Axsome Therapeutics Share in Jul 2025.

In Jul 2025 analysts predict a share price of $86.28. An increase of 14.06% compared to today's share price.

Stock Prediction for the Price of One Axsome Therapeutics Share in Aug 2025.

In Aug 2025 analysts predict a share price of $87.03. An increase of 15.06% compared to today's share price.

Stock Prediction for the Price of One Axsome Therapeutics Share in Sep 2025.

In Sep 2025 analysts predict a share price of $87.79. An increase of 16.06% compared to today's share price.

Stock Prediction for the Price of One Axsome Therapeutics Share in Oct 2025.

In Oct 2025 analysts predict a share price of $88.54. An increase of 17.06% compared to today's share price.

Stock Prediction for the Price of One Axsome Therapeutics Share in Nov 2025.

In Nov 2025 analysts predict a share price of $89.30. An increase of 18.06% compared to today's share price.

Stock Prediction for the Price of One Axsome Therapeutics Share in Dec 2025.

In Dec 2025 analysts predict a share price of $90.05. An increase of 19.06% compared to today's share price.

Axsome Therapeutics Stock Predictions 2030

Axsome Therapeutics Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $138.93. An increase of 83.67% compared to the previous month's estimate.

Axsome Therapeutics Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $140.21. An increase of 85.37% compared to the previous month's estimate.

Axsome Therapeutics Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $141.50. An increase of 87.07% compared to the previous month's estimate.

Axsome Therapeutics Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $142.78. An increase of 88.76% compared to the previous month's estimate.

Axsome Therapeutics Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $144.06. An increase of 90.46% compared to the previous month's estimate.

Axsome Therapeutics Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $145.35. An increase of 92.16% compared to the previous month's estimate.

Axsome Therapeutics Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $146.63. An increase of 93.86% compared to the previous month's estimate.

Axsome Therapeutics Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $147.92. An increase of 95.55% compared to the previous month's estimate.

Axsome Therapeutics Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $149.20. An increase of 97.25% compared to the previous month's estimate.

Axsome Therapeutics Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $150.48. An increase of 98.95% compared to the previous month's estimate.

Axsome Therapeutics Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $151.77. An increase of 100.64% compared to the previous month's estimate.

Axsome Therapeutics Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $153.05. An increase of 102.34% compared to the previous month's estimate.

P/E
0.00
Beta
1.12
Price-to-book Ratio
24.96
Market Cap
3.50B
TEV
3.46 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$114.08

Axsome Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Axsome Therapeutics, Inc.?

The following analysts have recently covered Axsome Therapeutics:

BofA Global Research
Cantor Fitzgerald & Co.
Guggenheim Securities, LLC
H.C. Wainwright & Co.
Ladenburg Thalmann & Company
Leerink Partners LLC
Marktfeld
Mizuho Securities USA LLC
Morgan Stanley
Piper Sandler Companies
TD Cowen
Truist Securities
William Blair & Company L.L.C.
Citigroup Inc
Citigroup Inc. Research
RBC Capital Markets
UBS Investment Bank
Baird
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Axsome Therapeutics, Inc.?

The following sell-side analysts have recently covered Axsome Therapeutics:

Gerberry, Jason Matthew
Duncan, Charles Cliff
Suneja, Yatin
Selvaraju, Raghuram
Kaplan, Matthew Lee
Goodman, Marc Harold
Paraskevopoulos, Michail
Suvannavejh, Graig C.
Purohit, Vikram
Amsellem, David A.
Thome, Joseph John-Charles
Lee, Joon So
Minter, Myles Robert
Hoang, David Timothy
Timashev, Leonid
Verma, Ashwani
Beatty, Joel Lawrence
(This information refers to the last 90 days.)